BIS manufactures more than 50 pharma products and specialises in injectable and ophthalmic pharmaceuticals for the mass market in DRC and is planning to expand into household cleaning products.
Key facts
- Status:
- Exited
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa, Central Africa
- Countries:
- Democratic Republic of Congo
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Health
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund:
- African Rivers Fund
- Fund Manager:
- XSML
- Start date
:
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- April 2016
- End date
:
For direct equity investments, this is the date at which CDC exited the investment.
For debt investments, this is the date at which the final debt repayment was made.
For funds, this is the date at which the fund was terminated.
For underlying fund investments, this is the date at which the fund manager exited the investment.
- December 2019
